Article ID Journal Published Year Pages File Type
1376158 Bioorganic & Medicinal Chemistry Letters 2008 5 Pages PDF
Abstract

4-(1,1-Dioxo-1,4-dihydro-1λ6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-one analogs were discovered as a novel class of inhibitors of HCV NS5B polymerase. Structure-based design led to the identification of compound 3a that displayed potent inhibitory activities in biochemical and replicon assays (1b IC50 < 10 nM; 1b EC50 = 1.1 nM) as well as good stability toward human liver microsomes (HLM t1/2 > 60 min).

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , , , , , , , , , ,